379 related articles for article (PubMed ID: 36805214)
41. Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response.
Valenti F; Falcone I; Ungania S; Desiderio F; Giacomini P; Bazzichetto C; Conciatori F; Gallo E; Cognetti F; Ciliberto G; Morrone A; Guerrisi A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917181
[TBL] [Abstract][Full Text] [Related]
42. Leveraging Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to Precision Medicine.
Ghosh D; Bernstein JA; Khurana Hershey GK; Rothenberg ME; Mersha TB
Front Immunol; 2018; 9():2727. PubMed ID: 30631320
[TBL] [Abstract][Full Text] [Related]
43. Integration of Omics and Phenotypic Data for Precision Medicine.
Zhao J; Feng Q; Wei WQ
Methods Mol Biol; 2022; 2486():19-35. PubMed ID: 35437716
[TBL] [Abstract][Full Text] [Related]
44. Integrative omics analyses broaden treatment targets in human cancer.
Sengupta S; Sun SQ; Huang KL; Oh C; Bailey MH; Varghese R; Wyczalkowski MA; Ning J; Tripathi P; McMichael JF; Johnson KJ; Kandoth C; Welch J; Ma C; Wendl MC; Payne SH; Fenyö D; Townsend RR; Dipersio JF; Chen F; Ding L
Genome Med; 2018 Jul; 10(1):60. PubMed ID: 30053901
[TBL] [Abstract][Full Text] [Related]
45. Multi-Omics Data Analysis Identifies Prognostic Biomarkers across Cancers.
Demir Karaman E; Işık Z
Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489460
[TBL] [Abstract][Full Text] [Related]
46. Patient-specific multi-omics models and the application in personalized combination therapy.
John A; Qin B; Kalari KR; Wang L; Yu J
Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
[TBL] [Abstract][Full Text] [Related]
47. Omics sciences and precision medicine in prostate cancer.
Medori MC; Micheletti C; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Calogero AE; Cannarella R; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):95-103. PubMed ID: 37994753
[TBL] [Abstract][Full Text] [Related]
48. [Identification of disease targets for precision medicine by integrative analysis of multi-omics data].
Xie BB; Yang YD; Ding N; Fang XD
Yi Chuan; 2015 Jul; 37(7):655-63. PubMed ID: 26351165
[TBL] [Abstract][Full Text] [Related]
49. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke.
Montaner J; Ramiro L; Simats A; Tiedt S; Makris K; Jickling GC; Debette S; Sanchez JC; Bustamante A
Nat Rev Neurol; 2020 May; 16(5):247-264. PubMed ID: 32322099
[TBL] [Abstract][Full Text] [Related]
50. "
Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
[TBL] [Abstract][Full Text] [Related]
51. MOBCdb: a comprehensive database integrating multi-omics data on breast cancer for precision medicine.
Xie B; Yuan Z; Yang Y; Sun Z; Zhou S; Fang X
Breast Cancer Res Treat; 2018 Jun; 169(3):625-632. PubMed ID: 29429018
[TBL] [Abstract][Full Text] [Related]
52. Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future.
Akhoundova D; Rubin MA
Cancer Cell; 2022 Sep; 40(9):920-938. PubMed ID: 36055231
[TBL] [Abstract][Full Text] [Related]
53. Insights into therapeutic targets and biomarkers using integrated multi-'omics' approaches for dilated and ischemic cardiomyopathies.
Kanapeckaitė A; Burokienė N
Integr Biol (Camb); 2021 May; 13(5):121-137. PubMed ID: 33969404
[TBL] [Abstract][Full Text] [Related]
54. Multi-omics data integration approaches for precision oncology.
Correa-Aguila R; Alonso-Pupo N; Hernández-Rodríguez EW
Mol Omics; 2022 Jul; 18(6):469-479. PubMed ID: 35470819
[TBL] [Abstract][Full Text] [Related]
55. Towards personalized medicine of colorectal cancer.
Aziz MA; Yousef Z; Saleh AM; Mohammad S; Al Knawy B
Crit Rev Oncol Hematol; 2017 Oct; 118():70-78. PubMed ID: 28917272
[TBL] [Abstract][Full Text] [Related]
56. Multi-omics integration and epilepsy: Towards a better understanding of biological mechanisms.
Chong D; Jones NC; Schittenhelm RB; Anderson A; Casillas-Espinosa PM
Prog Neurobiol; 2023 Aug; 227():102480. PubMed ID: 37286031
[TBL] [Abstract][Full Text] [Related]
57. An integrated Bayesian framework for multi-omics prediction and classification.
Mallick H; Porwal A; Saha S; Basak P; Svetnik V; Paul E
Stat Med; 2024 Feb; 43(5):983-1002. PubMed ID: 38146838
[TBL] [Abstract][Full Text] [Related]
58. Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis.
Xiao Y; Bi M; Guo H; Li M
EBioMedicine; 2022 May; 79():104001. PubMed ID: 35439677
[TBL] [Abstract][Full Text] [Related]
59. Novel biomarkers for cholangiocarcinoma: how can it enhance diagnosis, prognostication, and investigational drugs? Part-1.
Sinniah RS; Shapses MS; Ahmed MU; Babiker H; Chandana SR
Expert Opin Investig Drugs; 2021 Oct; 30(10):1047-1056. PubMed ID: 34579607
[TBL] [Abstract][Full Text] [Related]
60. Integrated multi-omics approach to distinct molecular characterization and classification of early-onset colorectal cancer.
Du M; Gu D; Xin J; Peters U; Song M; Cai G; Li S; Ben S; Meng Y; Chu H; Chen L; Wang Q; Zhu L; Fu Z; Zhang Z; Wang M
Cell Rep Med; 2023 Mar; 4(3):100974. PubMed ID: 36921601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
